Skip to main content.

pharmaceuticals

Picture of Kellie  Schmitt
NYT's Katie Thomas shares how she finds and vets stories of real people stung by ever-rising drug prices, and expert panelists provide key context for rounding out coverage.
Picture of Pauline Bartolone
California's Prop 61 faces strong opposition from the pharmaceutical industry, which has poured at least $109 million into defeating it.
Picture of Pauline Bartolone

The specialty drug Orkambi, for cystic fibrosis, has a sticker price of $259,000 per year. What's driving these astronomical costs for specialty drugs? And can California's budget cope?

Picture of Kellie  Schmitt

There’s no question that prescription drug prices are skyrocketing in the United States, and consumers aren’t happy about it. What’s more complicated, though, is understanding the complexities of the issue and reporting on what those soaring prices mean for consumers.

Picture of William Heisel

The ideas shared at last week's Health Journalism 2014 conference were innovative, provocative, and worth integrating into your daily reporting. Columnist William Heisel shares some of the most compelling lessons learned from this year's gathering.

Picture of William Heisel

GlaxoSmithKline, the largest drug company in Britain and one of the largest in the world, has made an industry first move.

Picture of Becca  Aaronson

Political powerhouse Texas Right to Life is working overtime to try to defeat a compromise measure aimed at improving state laws governing “end of life” medical decisions. But with time running out to get Senate Bill 303 passed, the fight over the legislation has shifted from political to personal.

Picture of William Heisel

Having grown up in a "natural is best" kind of environment, Nathanael Johnson became the family skeptic. His book looks at the polarized viewpoints in a world of "global warming, killer germs, and obesity."

Picture of Melissa Sweet

The controversy sparks questions about corporate influence and the new ways we fund journalism.

Picture of Kate  Benson

With only 17 to 18 percent of NIH grant applications funded this year - the lowest level on record - are RCTs costing millions, cost effective?

Pages

Announcements

The Center for Health Journalism is dedicated to supporting journalists covering two of the biggest stories of our time — the twin pandemics of COVID-19 and systemic racism and inequities in America. We provide reporters with intensive training instituteswebinars and tips about craft and content and are providing deep and sustained support for reporters and their newsrooms in this historic and difficult moment. You can donate through the USC web portal at this link. Pressed for time? You can also text to donate! No amount is too small; just send a text to 41-444 and type the message CHJ for further instructions.

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth